Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Slides:

Advertisements

Similar presentations

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Advertisements

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

Benny Weksler, MD, Jennifer L. Sullivan, MD

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Dhaval Chauhan, MD, Alexis K

Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial Ranjit John, MD, Yoshifumi Naka, MD,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Castigliano M. Bhamidipati, DO, MS, George J

Isaac George, MD, Steve Xydas, MD, Veli K

Less Is More in Post Pediatric Heart Transplant Care

Loretta Erhunmwunsee, MD, Brian C

Habib Jabagi, MD, MS, Diem T

Age-Related Outcomes of the Ross Procedure Over 20 Years

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure Allison P. Levin, BA, MSc,

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Karam Nam, MD, Yoon Sang Park, MD, Won Ho Kim, MD, PhD

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies Bahaaldin Alsoufi, MD, Scott Gillespie, MS, Dennis Kim,

Left Ventricular Assist Device Destination Therapy Versus Extended Criteria Cardiac Transplant Mani A. Daneshmand, MD, Keshava Rajagopal, MD, PhD, Brian.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Michiaki Imamura, MD, PhD, Amy M

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Raheel Rizwan, MD, Farhan Zafar, MD, Roosevelt Bryant, MD, James S

Characteristics of Malignant Pleural Mesothelioma in Women

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Dhaval Chauhan, MD, Alexis K

William M. Whited, MD, Paul Henley, BS, Erin M

Mitral Valve Repair for Degenerative Disease: A 20-Year Experience

Optimal Timing for Elective Early Primary Repair of Tetralogy of Fallot: Analysis of Intermediate Term Outcomes Michael E.A. Cunningham, MD, Mary T.

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Surgical Outcomes of Chronic Descending Dissections: Type I Versus III DeBakey Ivancarmine Gambardella, MD, FRCS, Mario Gaudino, MD, Christopher Lau,

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Bilateral Internal Thoracic Artery Grafts in Hemodialysis: A Single-Center Propensity Score Analysis Yoshinori Nakahara, MD, Shigehiko Yoshida, MD, Takeyuki.

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device Jiho Han, BS, Koji.

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Alexander Blair, MS, Paul A. Kurlansky, MD, Hiroo Takayama, MD, PhD, Yoshifumi Naka, MD, PhD The Annals of Thoracic Surgery Volume 103, Issue 1, Pages 41-48 (January 2017) DOI: 10.1016/j.athoracsur.2016.06.006 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Cohort derivation. (CF-LVAD = continuous-flow left ventricular assist device.) The Annals of Thoracic Surgery 2017 103, 41-48DOI: (10.1016/j.athoracsur.2016.06.006) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier curves for 90-day and 3-year survival, with 95% confidence interval (CI [blue shading indicates age 70+ years; red shading indicates ages 18 to 69, 18 to 59, or 18 to 59 years]). Septuagenarians (blue lines) versus patients aged 18 to 69 years (red line): (A) unadjusted and (D) propensity-matched. Septuagenarians (blue line) versus patients aged 18 to 59 years (red line): (B) unadjusted and (E) propensity-matched. Septuagenarians (blue line) versus patients aged 60 to 69 years (red line): (C) unadjusted and (F) propensity-matched. The Annals of Thoracic Surgery 2017 103, 41-48DOI: (10.1016/j.athoracsur.2016.06.006) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Posttransplant outcomes among septuagenarians, with 95% confidence interval (CI [blue shading indicates no assistance; red shading indicates some assistance; green shading indicates total assistance]). (A) Kaplan-Meier curves among septuagenarians stratified by functional status at time of transplant: 1, no assistance (blue line); 2, some assistance (red line); and 3, total assistance (green line). (B) Posttransplant follow-up functional status among 3-year survivors. The Annals of Thoracic Surgery 2017 103, 41-48DOI: (10.1016/j.athoracsur.2016.06.006) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions